NASDAQ:ARNA
Delisted
Arena Pharmaceuticals Stock News
$99.99
+0 (+0%)
At Close: May 27, 2022
's Top Upgrades, Downgrades For March 26, 2020
02:01pm, Thursday, 26'th Mar 2020
Upgrades
B. Riley FBR changed the rating for American Finance Trust Inc (NASDAQ: AFIN) from Neutral to Buy. American Finance Trust earned $0.24 in the fourth...
Arena Pharmaceuticals upgraded to Buy on recent selloff at BofA ARNA
10:34am, Thursday, 26'th Mar 2020
Arena Pharmaceuticals upgraded to Buy on recent selloff at BofA BofA ARNA
Arena Pharmaceuticals upgraded to Buy from Neutral at BofA ARNA
10:34am, Thursday, 26'th Mar 2020
Arena Pharmaceuticals upgraded to Buy from Neutral at BofA BofA ARNA
B of A Securities Upgrades Arena Pharmaceuticals to Buy, Raises Price Target to $56
12:00am, Thursday, 26'th Mar 2020Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expected to Post Quarterly Sales of $700,000.00
09:34am, Saturday, 21'st Mar 2020
Brokerages predict that Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) will post $700,000.00 in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Arena Pharmaceuticals’